Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
The Oncologist|February 28, 2016
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensTheodoros P Vassilakopoulos, Maria N Dimopoulou, Maria K Angelopoulou, et al.
Annals of Hematology|July 3, 2026
Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in GreeceEpameinondas Koumpis, Eva Minga, Persefoni Talimtzi, et al.
Leukemia & Lymphoma|January 28, 2012
Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphomaMaria Dimou, Maria K Angelopoulou, Gerassimos A Pangalis, et al.
Cancer Medicine|March 22, 2019
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registryPanagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, et al.
Hematological Oncology|February 21, 2017
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experienceMaria K Angelopoulou, Theodoros P Vassilakopoulos, Ioannis Batsis, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2018
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI SubtrialSébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz, et al.
Haematologica|January 18, 2015
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic LeukemiaCarol Moreno, Marco Montillo, Panayiotis Panayiotidis, et al.
Hematological Oncology|February 14, 2021
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomasMaria Dimou, Sotirios G Papageorgiou, Niki Stavroyianni, et al.
Cancers|January 23, 2024
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 PatientsTheodoros P Vassilakopoulos, Maria Arapaki, Panagiotis T Diamantopoulos, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
Pageof 11